Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Genesis Healthcare Inc (GEN)

The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small cap stocks that big investment banks don’t follow. Because of their pay structures, they have strong incentive to do the research necessary to beat the market. That’s why we pay close attention to what they think in small cap stocks. In this article, we take a closer look at Genesis Healthcare Inc (NYSE:GEN) from the perspective of those elite funds.

Genesis Healthcare Inc was in 12 hedge funds’ portfolios at the end of the third quarter of 2015. GEN investors should be aware of a decrease in enthusiasm from smart money lately. There were 14 hedge funds in our database with GEN positions at the end of the previous quarter. At the end of this article we will also compare GEN to other stocks, including Rush Enterprises, Inc. (NASDAQ:RUSHB), State Auto Financial (NASDAQ:STFC), and Textainer Group Holdings Limited (NYSE:TGH) to get a better sense of its popularity.

Follow Genesis Healthcare Inc. (NYSE:GEN)
Trade (NYSE:GEN) Now!

Today there are a lot of formulas investors have at their disposal to grade their holdings. A duo of the most underrated formulas are hedge fund and insider trading interest. Our researchers have shown that, historically, those who follow the top picks of the top fund managers can trounce the broader indices by a solid margin (see the details here).

With all of this in mind, we’re going to take a look at the recent action encompassing Genesis Healthcare Inc (NYSE:GEN).

Hedge fund activity in Genesis Healthcare Inc (NYSE:GEN)

Heading into Q4, a total of 12 of the hedge funds tracked by Insider Monkey were long this stock, a decrease of 14% from the second quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were increasing their holdings considerably (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Cannell Capital, managed by J. Carlo Cannell, holds the biggest position in Genesis Healthcare Inc (NYSE:GEN). Cannell Capital has a $9.5 million position in the stock, comprising 3.6% of its 13F portfolio. The second largest stake is held by Deerfield Management, managed by James E. Flynn, which holds a $9.4 million position; 0.4% of its 13F portfolio is allocated to the company. Remaining professional money managers that are bullish contain Phill Gross and Robert Atchinson’s Adage Capital Management, J. Alan Reid, Jr.’s Forward Management, and Krishen Sud’s Sivik Global Healthcare.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.